15 November 1991
COMMERCIAL ITEM DESCRIPTION
NYSTATIN ORAL SUSPENSION, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-N-37691 which is cancelled.
Shall be Nystatin Oral Suspension, USP.
Shall be in accordance with the requirement of the USP.
All ingredients shall be of a pharmaceutical grade.
Shall contain 100,000 units of Nystatin per ml within the applicable assay limits for the suspension.
Workmanship. The suspension shall be free from defects which detract from its appearance or impair its serviceability.
For Size I – Bottle (BT). Shall be supplied 60 ml in a commercially available bottle with a dropper calibrated at 1 ml and 2 ml (the dropper provided shall be compatible with and form a tight fit with the bottle), as specified, constitutes one unit.
For Size II – Bottle (BT). Shall be supplied 480 ml in a commercially available bottle. One bottle, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business